PharmaResearch Co., Ltd. (KOSDAQ:214450)
622,000
+5,000 (0.80%)
Sep 4, 2025, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 6.46 trillion as of September 4, 2025. Its market cap has increased by 381.46% in one year.
Market Cap
6.46T
Enterprise Value
6.22T
Revenue
449.81B
Ranking
n/a
PE Ratio
50.81
Stock Price
622,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 6.46T, an increase of 540.31%. That is a compound annual growth rate of 20.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 6,462.36B | 136.95% |
Dec 30, 2024 | 2,727.28B | 144.17% |
Dec 28, 2023 | 1,116.95B | 60.18% |
Dec 29, 2022 | 697.32B | -14.76% |
Dec 30, 2021 | 818.02B | 48.15% |
Dec 30, 2020 | 552.15B | 60.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.03T |
Celltrion | 37.78T |
ALTEOGEN | 24.77T |
Yuhan | 8,835.63B |
SK Biopharmaceuticals | 8,222.89B |
Peptron | 7,094.04B |
LigaChem Biosciences | 5,488.57B |
ABL Bio | 5,288.33B |